Ignite Creation Date:
2025-12-24 @ 4:34 PM
Ignite Modification Date:
2026-03-19 @ 9:57 AM
Study NCT ID:
NCT07214766
Status:
RECRUITING
Last Update Posted:
2025-12-04
First Post:
2025-10-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants
Sponsor:
Genentech, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GP44770
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None